get a key
steadybase-$ company BSX
account_id none on file
legal_name Boston Scientific Corp
ticker BSX
cik 885725
domain bostonscientific.com
entry_point_account_id none on file
name Boston Scientific Corporation
exchange NYSE
sector Health Care
hq Marlborough, MA, United States
calls 7 filings 44 executives 7 family 0
why_now
the deal structure enables us to maintain flexibility for additional potential tuck-in M&A or share repurchase

Jul 29, 2026 / receipt

calls
We do have some targeted discretionary spend reductions, you know, travel meetings. Actually, we have some programs going there, and we're just looking to accelerate those programs to deliver more savings.

Apr 23, 2025 / receipt, needs a key / Dan Brennan, CFO | earnings call 2025-04-23 | transcript dd7538fa-2c79-49b6-b8e9-465bdfedb309 | chars 21830-22035 | segment 22

We probably will see a little bit of an increase in SG&A. That's a normal trend that we see every Q2 each year where we have a particularly heavy industry trade show trend. and travel quarter with things like PCR, DDW, AUA, HRS, you know, all those types tend to be heavily concentrated in Q2.

Apr 27, 2022 / receipt, needs a key / Dan, other | earnings call 2022-04-27 | transcript 67675d0e-2119-4fd8-945c-9c6357c2630d | chars 38473-38766 | segment 38

Third quarter adjusted operating margin was 25.6%, again, in line with our expectations, driven by spend controls and lower travel offsetting the revenue headwinds.

Oct 27, 2021 / receipt, needs a key / Dan Brennan, CFO | earnings call 2021-10-27 | transcript dd2f66aa-6b17-44ff-872e-d995baf4e7c5 | chars 18061-18225 | segment 18

While many appropriate reductions remain in place at this time, such as limited travel and meetings, all offices and manufacturing sites are open, and most R&D employees have been able to return to their labs.

Jul 29, 2020 / receipt, needs a key / Dan, CFO | earnings call 2020-07-29 | transcript e5205d1d-4537-47da-9321-faf912ec001b | chars 20287-20496 | segment 20

I believe we'll obviously have some nice - tailwinds relative to travel and meetings and other things where we won't spend as much.

Jul 29, 2020 / receipt, needs a key / Dan, CFO | earnings call 2020-07-29 | transcript e5205d1d-4537-47da-9321-faf912ec001b | chars 33609-33740 | segment 34

Similarly, the ongoing launch of Lotus Edge in the U.S. and Japan has been challenged by COVID-19 restrictions that limit proctor travel and the delivery of training.

Apr 29, 2020 / receipt, needs a key / Dan, CFO | earnings call 2020-04-29 | transcript 87b33b12-96f9-452e-919b-292d4f421f09 | chars 16205-16371 | segment 16

As Mike mentioned, to offset the lower expected revenue, spend reductions are already in place, including cutbacks in travel, hiring, clinical programs, and certain longer payoff research and development projects.

Apr 29, 2020 / receipt, needs a key / Dan, CFO | earnings call 2020-04-29 | transcript 87b33b12-96f9-452e-919b-292d4f421f09 | chars 24304-24517 | segment 24

filings
Continued global expansion

ir_statement / Aug 25, 2026 / receipt

+14% - +15% vs. 2024 organic*

ir_statement / Aug 25, 2026 / receipt

+18% to +19% vs. 2024

ir_statement / Aug 25, 2026 / receipt

+75 to +100 bps vs. 2024

ir_statement / Aug 25, 2026 / receipt

Aim to improve gross margin over the LRP

ir_statement / Aug 25, 2026 / receipt

disciplined approach to discretionary spend

ir_statement / Aug 25, 2026 / receipt

Expect to drive meaningful SG&A leverage

ir_statement / Aug 25, 2026 / receipt

Adjusted SG&A* 36.8% 36.1% 35.1% 34.6% 2013 2016 2019 2022 2025E 2026E-2028E

ir_statement / Aug 25, 2026 / receipt

Continuously optimizing org structure

ir_statement / Aug 25, 2026 / receipt

Disciplined approach to spend allows for investments in future growth

ir_statement / Aug 25, 2026 / receipt

Efficiency driven by AI capabilities

ir_statement / Aug 25, 2026 / receipt

Implementing enhanced ERP system

ir_statement / Aug 25, 2026 / receipt

executives
Cheryl Pegus director - receipt
Dan Brennan CFO - receipt
David C. Habiger director - receipt
David S. Wichmann director - receipt
Emily Woodworth (Collins) Senior Vice President - receipt
Jonathan Monson Senior Vice President - receipt
Mike Mahoney CEO - receipt
familynone on file
upcoming
2026-10-28 08:00 ET earnings call scheduled webcast / ir
changes
2024-07-30 director, appointed sec_8k
2024-05-10 director, appointed sec_8k
2024-01-31 Senior Vice President, appointed sec_8k
2024-01-31 Senior Vice President, appointed sec_8k
2021-06-24 director, appointed sec_8k
mcp_package_hint
steadybase-$